thiazolidines has been researched along with Cardiovascular Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatware, K; Patil, K; Sharma, R; Sharma, S | 1 |
| Morishita, R; Nakagami, H | 1 |
| Domergue, J; Haufroid, V; Lison, D | 1 |
| Bhatt, DL; De Rycke, Y; Hajage, D; Steg, PG; Tubach, F | 1 |
| Rapezzi, C; Volpe, M | 1 |
| Silacci, P | 1 |
| Kawakami, M; Kuroki, M | 1 |
| Gross, B; Staels, B | 1 |
| Nakamura, T; Okano, R; Okuda, S; Seo, Y; Uchiyama, H | 1 |
| Ikeda, T; Iwata, K; Tanaka, Y | 1 |
5 review(s) available for thiazolidines and Cardiovascular Diseases
| Article | Year |
|---|---|
Review on Chemistry, Analysis and Pharmacology of Teneligliptin: A Novel DPP-4 Inhibitor.
Topics: Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Glucagon-Like Peptide 1; Half-Life; Humans; Pyrazoles; Thiazolidines | 2020 |
Teneligliptin : expectations for its pleiotropic action.
Topics: Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Pyrazoles; Thiazolidines | 2015 |
Advanced glycation end-products as a potential target for treatment of cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Glycation End Products, Advanced; Humans; Hypertension; Rats; Thiadiazoles; Thiazolidines | 2002 |
[Aminoguanidine and other AGE inhibitors].
Topics: Amides; Animals; Arteriosclerosis; Cardiovascular Diseases; Cataract; Clinical Trials as Topic; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Retinopathy; Disease Models, Animal; Drug Design; Glycation End Products, Advanced; Guanidines; Humans; Hydrazines; Hypoglycemic Agents; Thiadiazoles; Thiazoles; Thiazolidines | 2002 |
PPAR agonists: multimodal drugs for the treatment of type-2 diabetes.
Topics: Animals; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Homeostasis; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Lipoproteins; Peroxisome Proliferator-Activated Receptors; PPAR alpha; PPAR delta; PPAR gamma; Thiazolidines | 2007 |
1 trial(s) available for thiazolidines and Cardiovascular Diseases
| Article | Year |
|---|---|
Long-term effect of epalrestat on cardiac autonomic neuropathy in subjects with non-insulin dependent diabetes mellitus.
Topics: Aged; Aged, 80 and over; Aldehyde Reductase; Autonomic Nervous System Diseases; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Electrocardiography; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Rhodanine; Statistics, Nonparametric; Thiazolidines | 1999 |
4 other study(ies) available for thiazolidines and Cardiovascular Diseases
| Article | Year |
|---|---|
No evidence of cardiovascular toxicity in workers exposed below 5 ppm carbon disulfide.
Topics: Adult; Biomarkers; C-Reactive Protein; Carbon Disulfide; Cardiotoxicity; Cardiovascular Diseases; Chemical Industry; Cholesterol; Cross-Sectional Studies; Environmental Monitoring; Humans; Middle Aged; Occupational Diseases; Occupational Exposure; Regression Analysis; Risk Factors; Thiazolidines; Time; Young Adult | 2016 |
On the use of propensity scores in case of rare exposure.
Topics: Cardiovascular Diseases; Computer Simulation; Female; Humans; Male; Models, Statistical; Monte Carlo Method; Observational Studies as Topic; Propensity Score; Proportional Hazards Models; Thiazolidines | 2016 |
[Residual risk in cardiovascular prevention].
Topics: Atherosclerosis; Blood Pressure; Body Weight; Cannabinoid Receptor Antagonists; Cannabinoids; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Follow-Up Studies; Humans; Hypolipidemic Agents; Kaplan-Meier Estimate; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Risk Factors; Smoking Cessation; Thiazolidines; Time Factors | 2008 |
Effectiveness of aldose reductase inhibitors for diabetic gastroenteropathy with constipation.
Topics: Aldehyde Reductase; Autonomic Nervous System Diseases; Cardiovascular Diseases; Constipation; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Enzyme Inhibitors; Female; Gastrointestinal Motility; Hemodynamics; Humans; Intestinal Pseudo-Obstruction; Middle Aged; Rhodanine; Shock, Septic; Thiazolidines | 1997 |